LOOK AT WHAT IS IN THE CHILDHOOD VACCINES FROM THE CDC.
1. HepB (Hepatitis B)
This vaccine is contraindicated for name because it contains Lactate dehydrogenase-elevating virus (LDV) which is a mouse arterivirus pathogenic infection of neurons in the central nervous system. *The vaccine also contains Envelope E protein - 75 amino acids long, the envelope (E) protein is the smallest of the four structural proteins that make up the SARS-CoV-2 viral particle and is essential for the virus to infect cells. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Safety Datasheet: ENGERIX-B PRESERVATIVE FREE = * HEPATITIS B SURFACE ANTIGEN https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.p df
Vaccine – Hepatitis B (Recombinant DNA) Vaccine (Absorbed)
Composition/information on ingredients: Disodium Hydrogen Phosphate https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.p df
*Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282743/
2. RV* Rotavirus
This vaccine is contraindicated for name because it increased risk of intussusception in vaccinated infants. Intussusception is a medical emergency that needs care right away. It is the most common abdominal emergency in children under 2 years old. An associated protein coding gene (ingredient) is CRAT (Carnitine O-acetyltransferase). Diseases Associations are: Acute diabetes complication and Ischemia; and diseases associated with CRAT
include Neurodegeneration With Brain Iron Accumulation 8 and Neurodegeneration With Brain Iron Accumulation (NBIA). NBIA are neurologic disorders, causing include; muscular spasms, twisting, and repetitive movements, spasticity, parkinsonism (slurred or slow speech, stiffness of the muscles, slow movement, and visible tremors), inability to coordinate movements (ataxia), neuropsychiatric abnormalities (confusion, disorientation, seizures, stupor, dementia), and eye problems, such as optic atrophy or retinal degeneration. Cerebellar atrophy is common in many cases. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
https://www.sciencedirect.com/science/article/abs/pii/S0264410X21012822
Supporting studies/evidence:
What Is Intussusception?
https://kidshealth.org/en/parents/intussusception.html https://www.mayoclinic.org/diseases-conditions/intussusception/symptoms-causes/syc-20351452
Neurodegeneration with Brain Iron Accumulation
https://rarediseases.info.nih.gov/diseases/11899/neurodegeneration-with-brain-iron-accumulation
3. DTaP Diphtheria, Pertussis, & Tetanus - BOOSTRIX (FDA recommended)
This vaccine is contraindicated for name because it contains Recombinant Exotoxin A of Pseudomonas aeruginosa. Exotoxin A is a potent cytotoxin and is known to be lethal. Exotoxin A causes disease by inhibition of protein synthesis, direct cytopathic effects, and interference with cellular immune functions of the host/ child. BOOSTRIX also is linked to the protein Mucin-1 (human), which contributes to cellular processes and dysregulation, and can facilitate in distinct human diseases. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
The role of exotoxin A in pseudomonas disease and immunity https://pubmed.ncbi.nlm.nih.gov/6419320/
Mucin-1 (human)
Mucin 1 - Protein-Disease Associations - https://pubchem.ncbi.nlm.nih.gov/protein/P15941 - section=Diseases-and- Phenotypes
Diphtheria toxoids
https://www.cdc.gov/vaccines/pubs/pinkbook/dip.html
4. Hib* Haemophilus influenzae type b
PedvaxHIB (PRP-OMP, Merck) -
Synonym: Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol Modified For Conjugation
This vaccine is contraindicated for name. because it contains the chemical Atropine, which is registered as a hazardous substances, and an environmental contaminant. Atropine in toxic amounts leads to drowsiness, stupor, convulsions, & coma, and death. Symptoms of atropine toxicity include: dryness of the mouth; flushed, hot, & dry skin; dilated & nonreactive pupils; tachycardia; hallucinations; & restlessness. Seizures without prior evidence of hallucinations or delirium have followed the use of atropine in children. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
haemophilus b conjugate vaccine (meningococcal protein conjugate) https://www.drugs.com/pro/pedvaxhib.html
Atropine -
Atropine has been used as a premedication in obstetric anesthesia, as a test of fetoplacental insufficiency, & in the diagnosis of fetal asphyxia (atropine given to the mother produces changes in the fetal heart rate: first bradycardia, then tachycardia). There is evidence of rapid placental transfer of atropine. https://pubchem.ncbi.nlm.nih.gov/source/hsdb/2199
Atropine Data sheet –
https://pubchem.ncbi.nlm.nih.gov/compound/Atropine - section=GHS-Classification
Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol Modified For Conjugation
https://gsrs.ncats.nih.gov/ginas/app/beta/substances/MC95ZF3C5A https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46KSF1PRP7
5. PCV13, PCV15 (Pneumococcal disease)
Name: Vaxneuvance (Merck) Pneumococcal 15-valent - suspension for injection in pre-filled syringe
This vaccine is contraindicated for name because it contains Amlodipine (Norvasc). Amlodipine is an antihypertensive agent, and a vasodilator agent; which can cause a decrease in blood pressure. *GHS Hazard Statements - Toxic if swallowed. Danger Acute toxicity, oral corrosive, and an environmental contaminant. Causes serious eye damage. Causes damage to organs through prolonged or repeated exposure. *Warning: Specific target organ toxicity, repeated exposure. Very toxic to aquatic life with long lasting effects. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence
Amlodipine https://pubchem.ncbi.nlm.nih.gov/compound/amlodipine
Norvasc
https://www.mayoclinic.org/drugs-supplements/amlodipine-oral-route/description/drg-20061784
Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient] (Code N0000179488)
https://nciterms.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NDFRT&version=February2018&code=N0 000179488&ns=NDFRT&type=all&key=null&b=1&n=0&vse=null
6. IPV - Poliovirus Vaccine, inactivated
This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can produce neurotoxicity, ototoxicity and/or nephrotoxicity. Neomycin is associated with delayed-onset irreversible deafness, renal failure and death due to neuromuscular blockade (regardless of the status of renal function). GHS Hazard Statements: Harmful if swallowed: Acute toxicity, oral. May cause a serious allergic skin reaction May cause allergy or asthma symptoms or breathing difficulties if inhaled. Inactivated poliovirus vaccine administration has been associated with Guillain-Barre Syndrome. *Neomycin is used in veterinary medicine as a bactericidal drug. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Neomycin https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
7. COVID-19** Coronavirus disease 2019
This recombinant nanoparticle vaccine is contraindicated for name because it contains the full-length spike glycoprotein of the prototype strain plus *Matrix-M adjuvant. Matrix-M adjuvant induces early activation of innate immune cells at the injection site and in the draining lymph nodes. It is unsafe when used in larger amounts as medicine. The Matrix-M adjuvant consists of two distinct fractions of saponins purified from the Quillaja saponaria Molina tree, combined with cholesterol and phospholipids to form 40-nm open cage-like nanoparticles. Quillaia contains high amounts of tannins which can cause stomach problems, as well as kidney and liver damage. Quillaia also contains chemicals called oxalates, which can cause kidney stones. Additional serious adverse events with this vaccine: cases of myocarditis, cases of pericarditis, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in hospitalization or death following administration of the Novavax COVID-19 Vaccine, Adjuvanted. *NVX-CoV2373 in the United States has received Emergency Use Authorization, it is not FDA approved
This presents a clear medical danger to name because this toxins, and the additional adverse health concerns would be exacerbated by introduction of this substance to his/her body.
FDA Briefing Document Novavax COVID-19 Vaccine
https://www.fda.gov/media/158912/download
Supporting studies/evidence
Matrix-MTM Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041451
Additional information on Novavax
*The Novavax COVID-19 Vaccine, Adjuvanted is a suspension for intramuscular injection.
Product label Generic name: nvx-cov2373 Dosage form: injection, suspension Drug class: Viral vaccines Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report all vaccine administration errors, all serious adverse events, cases of myocarditis, cases of pericarditis, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in hospitalization or death following administration of the Novavax COVID-19 Vaccine, Adjuvanted.
See “MANDATORY REQUIREMENTS FOR THE NOVAVAX COVID-19 VACCINE, ADJUVANTED ADMINISTRATION UNDER EMERGENCY USE AUTHORIZATION” for reporting requirements. https://www.drugs.com/pro/covid-19-vaccine-novavax.html
8. Flu† Influenza
This vaccine is contraindicated for name because it can trigger severe allergic reactions such as asthma and precaution is advised with use of quadrivalent live attenuated influenza vaccine (LAIV4) in persons aged ≥5 years because of concerns for wheezing events. Reactions include, in addition to asthma (e.g., anaphylaxis) egg, (egg protein) neuralgia, paresthesia, convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse myelitis, Guillain-Barre Syndrome, dizziness, hypoesthesia, tremor, facial or cranial nerve paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell's Palsy), exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis, eosinophilic meningitis, vaccine associated encephalitis. This presents a clear medical danger to name because these potentially dangerous medical concern would be exacerbated by introduction of this vaccine to his/her body.
Supporting studies/evidence:
FLUMIST
QUADRIVALENT safely and effectively. See full prescribing information for FLUMIST https://www.fda.gov/vaccines-blood-biologics/lot-release/influenza-vaccine-2022-2023-season
Afluria Quadrivalent 2022-2023 (injection)
https://www.drugs.com/mtm/afluria-quadrivalent-2022-2023-injection.html https://www.drugs.com/sfx/afluria-quadrivalent-side-effects.html
9. MMR Measles, Mumps, & Rubella
This vaccine is contraindicated for name, and certain individuals including those with: a history of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic reaction to *Neomycin; individuals who are immunodeficient or immunosuppressed due to disease or medical therapy; an active febrile illness. Adverse concerns/ reactions are seizure or family history of febrile seizures; immediate-type hypersensitivity reactions to eggs; and thrombocytopenia. These medical concerns and reactions presents a clear medical danger to name due to ingredients that would be exacerbated by introduction of these substance to his/her body.
Supporting studies/evidence:
MMR Vaccine - Priorix https://www.chop.edu/news/news-views-what-should-i-know-about-new-mmr-vaccine-priorix
Priorix
https://ca.gsk.com/media/6254/priorix.pdf
*Neomycin
https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
10. Varicella (Chickenpox)
This vaccine is contraindicated for name because it contains the chemical compound, ALB - albumin (human). Implicated in several diseases, including blood protein disease; hepatobiliary system cancer (multiple); hyperthyroxinemia; middle cerebral artery infarction; and psoriasis. Biomarker of several diseases, including carcinoma (multiple); heart disease (multiple); hematologic cancer (multiple); liver disease (multiple); and lung disease (multiple). This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body. *Note: This gene has been reviewed for its involvement in coronavirus biology, and is relevant for COVID- 19 prognosis.
Supporting Studies/evidence:
ALB - albumin (human). https://pubchem.ncbi.nlm.nih.gov/gene/213
Albumin (human)
https://www.drugs.com/mtm/albumin-human.html
11. HepA‡ Hepatitis A
This vaccine is contraindicated for name because it contains Aluminum. Aluminum negatively effects the central nervous system and bones. Aluminum binds to dietary phosphorus and impairs gastrointestinal absorption of aluminum. The decreased phosphate body burden results in osteomalacia and rickets. Aluminum neurotoxicity is believed to involve different mechanisms. Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier, cholinergic activity, signal transduction pathways. It has been suggested that aluminum’s interaction with estrogen receptors increases the expression of estrogen-related genes and thereby contributes to the progression of breast cancer. This presents a clear medical danger to name because this chemical compound is toxic, and would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Havrix (Hepatitis A Vaccine) injectable suspension, for intramuscular use https://ca.gsk.com/media/6243/havrix.pdf
Al2O3 nanoparticles induce mitochondria-mediated cell death and upregulate the expression of signaling genes in human mesenchymal stem cells
https://pubmed.ncbi.nlm.nih.gov/23132795/
12. Tdap: ≥7 yrs.
This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can produce neurotoxicity, ototoxicity and/or nephrotoxicity. Severe allergic reaction (e.g., anaphylaxis) and progressive neurologic disorders, include - hypersensitivity and encephalopathy. Neomycin is associated with delayed-onset irreversible deafness, renal failure and death due to neuromuscular blockade (regardless of the status of renal function). Neomycin is used in veterinary medicine as a bactericidal drug. GHS Hazard Statements: Harmful if swallowed - Warning Acute toxicity, oral. May cause an allergic skin reaction May cause allergy or asthma symptoms or breathing difficulties if inhaled. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Neomycin https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
Neomycin
https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
13 (HPV) Human Papillomavirus
This vaccine is contraindicated for name because it contains serious health concerns for anyone with allergic food (yeast), Adverse side effects associated HPV vaccine are: difficulty breathing, wheezing (bronchospasm), hives, rash, vomiting, swollen glands (neck, armpit, or groin) joint pain unusual tiredness, weakness, or confusion, chills, generally feeling unwell, leg pain, shortness of breath, chest pain, aching muscles, muscle weakness, seizure, bleeding or bruising more easily than normal, skin infection. *There are 85 Papillomavirus type strains (including non -human strains) linked to this CDC Recommended Vaccine. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Patient Information about GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant) https://www.fda.gov/media/90070/download?attachment
*Patent Summary: Vaccine against HPV – 85 linked Papillomavirus strains
https://pubchem.ncbi.nlm.nih.gov/patent/EP-2318042-B1 - section=Linked-Proteins
14. Meningococcal (MenACWY-D: ≥9 mos, MenACWY-CRM: ≥2 mos, MenACWY-TT: ≥2years)
This vaccine is contraindicated for name because it contains the chemical compound, Diphtheria Toxoid. As an ingredient, it is a carrier protein for polysaccharides and haptens to make them immunogenic. The toxicity of Diphtheria Toxoid (CRM197) can cause damage to yeast cells and some mammalian cell lines. Haptens are small molecules that elicit an immune response when attached to a large carrier such as a protein; and they activate responses involving inflammatory cytokines. *Examples of post market side adverse effects, associated with this vaccine include (not limited too) - Blood and Lymphatic System Disorders, Lymphadenopathy, Immune System Disorders, Hypersensitivity reactions such as anaphylaxis/anaphylactic reaction, wheezing, difficulty breathing, upper airway swelling, urticaria, erythema, pruritus, and hypotension. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
LABEL: MENACTRA-
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen injection, solution https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d8781ff-9366-462c-8161- 6e958f44fcb4&audience=consumer - S11
Menactra, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
https://www.vaccineshoppe.com/assets/pdf/vsh/pi/menactrapi.pdf
15. Meningococcal serogroup B vaccination
This vaccine is contraindicated for name because it contains an ingredient, Fc gamma receptor and transporter (FCGRT). This gene encodes a receptor that binds immunoglobulin G; and also binds immunoglobulin G to protect the antibody from degradation. Due to alternative splicing caused by interaction with various ingredients in the vaccine, multiple transcript variant can occur, and trigger autoimmune reactions. Disease associated with FCGRT is Myasthenia gravis. Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth, throat and limbs. The disease can strike anyone at any age. A myasthenia gravis crisis can involve difficulty in swallowing or breathing. The cause of myasthenia gravis is unknown and there is no cure. *The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Meningococcal group B vaccine Side Effects
https://www.drugs.com/sfx/meningococcal-group-b-vaccine-side-effects.html
Myasthenia Gravis
https://www.hopkinsmedicine.org/health/conditions-and-diseases/myasthenia-gravis
16. (PPSV23) pneumococcal polysaccharides vaccine (PPSV), 23-valent
This vaccine is contraindicated for name because it contains such harsh ingredients, and known toxins that trigger life threatening allergic reactions, and onset infections. A few examples of these life-threatening reactions are: Febrile convulsion, which are seizures or convulsions that occur in young children. Symptoms may include: loss of consciousness or passing out; uncontrollable shaking; eye rolling; rigid (stiff) limbs. Myocardial infarction (commonly called a heart attack) is an extremely dangerous condition that happens because of a lack of blood flow to your heart muscle; often resulting in death. Injection Cellulitis; Cellulitis is a potentially serious bacterial skin infection. The affected skin is swollen and inflamed and is typically painful and warm to the touch. Cellulitis is usually a superficial infection of the skin; if severe or if left untreated, it can spread into the lymph nodes and bloodstream and rapidly become life-threatening. These potential reactions presents a clear medical danger to name because these reactions would be exacerbated by introduction of this substance to his/her body.
PNEUMOVAX 23 is indicated to help prevent pneumococcal disease caused by 23 serotypes
https://www.merckvaccines.com/pneumovax23/
Pneumovax 23 Side Effects
Generic name: pneumococcal 23-polyvalent vaccine
https://www.drugs.com/sfx/pneumovax-23-side-effects.html
Febrile Seizures
https://www.ninds.nih.gov/health-information/disorders/febrile-seizures
Heart Attack (Myocardial Infarction)
https://my.clevelandclinic.org/health/diseases/16818-heart-attack-myocardial-infarction
Cellulitis
https://www.mayoclinic.org/diseases-conditions/cellulitis/symptoms-causes/syc-20370762
17. (DEN4CYD: 9-16 yrs.)
1. This vaccine is contraindicated for name because it has extreme adverse side effects, causing damaging health concerns. Some of them were: bleeding (tourniquet, petechiae or any bleeding) plus plasma leakage; Shock and hypotension with tachycardia, weak pulse and poor perfusion; Bleeding requiring blood transfusion; Encephalopathy i.e., unconsciousness or poor conscious state; poor conscious state or unconsciousness; Myocarditis, and pericarditis.
2. Sanofi Pasteur licensed the first dengue vaccine (Dengvaxia) in Mexico in 2015, and more than 20 countries, thereafter, based on the safety and efficacy demonstrated in two phase III trials and a single season of disease surveillance. Unfortunately, the optimism that a dengue vaccine was finally available quickly became disappointment when a safety signal was observed in vaccine recipients who were dengue non-immune at the time of vaccine administration44,45.
In the third year of the phase III clinical trial, the youngest, non-immune vaccine recipients experienced increased rates of hospitalized and severe dengue compared to their unvaccinated peers46. These potential reactions presents a clear medical danger to name because these toxins and/or reactions would be exacerbated by introduction of this substance to his/her body.
1. Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
https://classic.clinicaltrials.gov/ct2/show/NCT01374516
2. Is new dengue vaccine efficacy data a relief or cause for concern?
https://www.nature.com/articles/s41541-023-00658-2
*Additional Information:
HepA Hepatitis A Vaccines - Associated Disorders and Diseases
Autism Spectrum Disorder
Multiple Sclerosis, Chronic Progressive Bone Diseases, Metabolic Cardiovascular Diseases
Brain Diseases
Anemia
Eye Diseases
Memory Disorders
Cognition Disorders
Granuloma
Heart Defects, Congenital
Epilepsy, Tonic-Clonic
Fragile X Syndrome
Inflammation
Lung Diseases
Osteomalacia
Lymphadenitis
Nerve Degeneration
Parkinson Disease
Neoplasms
Osteoporosis
Bronchial Hyperreactivity
Multiple Sclerosis, Relapsing-Remitting Neurodegenerative Diseases
Chronic Kidney Disease-Mineral and Bone Disorder Chemical and Drug Induced Liver Injury
Poisoning
Diabetes Complications
Dyslipidemias
Respiratory Tract Diseases
Neurotoxicity Syndromes
Weight Loss
Heavy Metal Poisoning
Patent - Vaccine against HPV - GLAXOSMITHKLINE BIOLOG SA (BE)
(HPV) Human Papillomavirus Stains - Presented as linked
Proteins in Vaccine
P50805 P08341 P50807 P03104 P11326 P22163 Q02273 Q02274 P06456 P06417 P04012 P03099 P25486 P17388 P06416 P27232 P24838 P27557 P27233 P50815 P50816 P36741 P22424 P26536 P36743 P26535 P26537 P69899 P27964 P36733 P36734 Q05137 Q02514 Q02050 Q02051 Q02515 P36731 P36740 P36742
Major capsid protein L1 (Xipapillomavirus 1)
Major capsid protein L1 (Bos taurus papillomavirus 4)
Major capsid protein L1 (Bos taurus papillomavirus 6)
Major capsid protein L1 (Deltapapillomavirus 2)
Major capsid protein L1 (Deltapapillomavirus 1)
Major capsid protein L1 (Alpha papillomavirus 12)
Major capsid protein L1 (human papillomavirus 13)
Major capsid protein L1 (Pygmy chimpanzee papillomavirus type 1) Major capsid protein L1 (Chaffinch papillomavirus)
Major capsid protein L1 (Human papillomavirus type
Major capsid protein L1 (human papillomavirus 11)
Major capsid protein L1 (Human papillomavirus type 1a)
Major capsid protein L1 (Human papillomavirus type 2a)
Major capsid protein L1 (human papillomavirus 31)
Major capsid protein L1 (human papillomavirus 33)
Major capsid protein L1 (human papillomavirus 35)
Major capsid protein L1 (human papillomavirus 39)
Major capsid protein L1 (Human papillomavirus type 41)
Major capsid protein L1 (human papillomavirus 42)
Major capsid protein L1 (human papillomavirus 43)
Major capsid protein L1 (human papillomavirus 44)
Major capsid protein L1 (human papillomavirus 45)
Major capsid protein L1 (human papillomavirus 47)
Major capsid protein L1 (human papillomavirus 51)
Major capsid protein L1 (human papillomavirus 56)
Major capsid protein L1 (human papillomavirus 58)
Major capsid protein L1 (Human papillomavirus type 5b)
Major capsid protein L1 (Human papillomavirus type 6b)
Major capsid protein L1 (Human papillomavirus type me180) Major capsid protein L1 (human papillomavirus 12)
Major capsid protein L1 (human papillomavirus 14)
Major capsid protein L1 (Human papillomavirus 15)
Major capsid protein L1 (Human papillomavirus 17) Major capsid protein L1 (Human papillomavirus 19) Major capsid protein L1 (human papillomavirus 25) Major capsid protein L1 (human papillomavirus 30)
Major capsid protein L1 (Human papillomavirus 3) Major capsid protein L1 (human papillomavirus 40) Major capsid protein L1 (Human papillomavirus type 49)
Q07860 Major capsid protein L1 (Human papillomavirus 4) Q05138 Major capsid protein L1 (human papillomavirus 52) Q05136 Major capsid protein L1 (Human papillomavirus type 7) Q02480 Major capsid protein L1 (Human papillomavirus 9) Q07861 Major capsid protein L1 (Human papillomavirus type 63) Q07874 Major capsid protein L1 (Human papillomavirus 65)
P50786 Major capsid protein L1 (human papillomavirus 20)
P50787 Major capsid protein L1 (human papillomavirus 21)
P03102 Major capsid protein L1 (Papillomavirus sylvilagi
(STRAIN KANSAS))
P50791 Major capsid protein L1 (Human papillomavirus 28)
P50792 Major capsid protein L1 (Human papillomavirus 29)
P50820 Major capsid protein L1 (Human papillomavirus type 55) P50822 Major capsid protein L1 (Human papillomavirus type 61) P50824 Major capsid protein L1 (Human papillomavirus type 64) Q80961 Major capsid protein L1 (human papillomavirus 66)
P50825 Major capsid protein L1 (human papillomavirus 67)
P50826 Major capsid protein L1 (human papillomavirus 69)
P69898 Major capsid protein L1 (Human papillomavirus type 6a)
P50788 Major capsid protein L1 (Human papillomavirus 22)
P50789 Major capsid protein L1 (Human papillomavirus 23)
P50790 Major capsid protein L1 (human papillomavirus 24)
P50812 Major capsid protein L1 (human papillomavirus 36)
P50813 Major capsid protein L1 (Human papillomavirus 37)
P50814 Major capsid protein L1 (Human papillomavirus 38)
P50793 Major capsid protein L1 (Human papillomavirus type 70) P50806 Major capsid protein L1 (Epsilon papillomavirus 1)
P50817 Major capsid protein L1 (Human papillomavirus type 48)
P50818 Major capsid protein L1 (Human papillomavirus type 50)
P50821 Major capsid protein L1 (Human papillomavirus type 60) P54669 Major capsid protein L1 (human papillomavirus 68) Q9IR52 Major capsid protein L1 (human papillomavirus 82) P36736 Major capsid protein L1 (human papillomavirus 27) P22162 Major capsid protein L1 (human papillomavirus 57) P36732 Major capsid protein L1 (Human papillomavirus type 10) P03101 Major capsid protein L1 (Human papillomavirus type 16) P06794 Major capsid protein L1 (Human papillomavirus type 18) P36735 Major capsid protein L1 (Human papillomavirus type 26)
P36737 Major capsid protein L1 (Human papillomavirus type 32)
P36738 Major capsid protein L1 (Human papillomavirus type 34)
Q05113 Major capsid protein L1 (Human papillomavirus type 53)
P06917 Major capsid protein L1 (Human papillomavirus 5)
P50823 Major capsid protein L1 (human papillomavirus 62)
P03103 Major capsid protein L1 (Deltapapillomavirus 4)
Q89828 Major capsid protein L1 (Canine oral papillomavirus (strain Y62)) P50819 Major capsid protein L1 (Human papillomavirus type 54)
P06458 Major capsid protein L1 (Bos taurus papillomavirus 2)
1. HepB (Hepatitis B)
This vaccine is contraindicated for name because it contains Lactate dehydrogenase-elevating virus (LDV) which is a mouse arterivirus pathogenic infection of neurons in the central nervous system. *The vaccine also contains Envelope E protein - 75 amino acids long, the envelope (E) protein is the smallest of the four structural proteins that make up the SARS-CoV-2 viral particle and is essential for the virus to infect cells. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Safety Datasheet: ENGERIX-B PRESERVATIVE FREE = * HEPATITIS B SURFACE ANTIGEN https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.p df
Vaccine – Hepatitis B (Recombinant DNA) Vaccine (Absorbed)
Composition/information on ingredients: Disodium Hydrogen Phosphate https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_SMKLPH_ENGERIXB_SYR_TIP_LOK_10MCG0.p df
*Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282743/
2. RV* Rotavirus
This vaccine is contraindicated for name because it increased risk of intussusception in vaccinated infants. Intussusception is a medical emergency that needs care right away. It is the most common abdominal emergency in children under 2 years old. An associated protein coding gene (ingredient) is CRAT (Carnitine O-acetyltransferase). Diseases Associations are: Acute diabetes complication and Ischemia; and diseases associated with CRAT
include Neurodegeneration With Brain Iron Accumulation 8 and Neurodegeneration With Brain Iron Accumulation (NBIA). NBIA are neurologic disorders, causing include; muscular spasms, twisting, and repetitive movements, spasticity, parkinsonism (slurred or slow speech, stiffness of the muscles, slow movement, and visible tremors), inability to coordinate movements (ataxia), neuropsychiatric abnormalities (confusion, disorientation, seizures, stupor, dementia), and eye problems, such as optic atrophy or retinal degeneration. Cerebellar atrophy is common in many cases. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
https://www.sciencedirect.com/science/article/abs/pii/S0264410X21012822
Supporting studies/evidence:
What Is Intussusception?
https://kidshealth.org/en/parents/intussusception.html https://www.mayoclinic.org/diseases-conditions/intussusception/symptoms-causes/syc-20351452
Neurodegeneration with Brain Iron Accumulation
https://rarediseases.info.nih.gov/diseases/11899/neurodegeneration-with-brain-iron-accumulation
3. DTaP Diphtheria, Pertussis, & Tetanus - BOOSTRIX (FDA recommended)
This vaccine is contraindicated for name because it contains Recombinant Exotoxin A of Pseudomonas aeruginosa. Exotoxin A is a potent cytotoxin and is known to be lethal. Exotoxin A causes disease by inhibition of protein synthesis, direct cytopathic effects, and interference with cellular immune functions of the host/ child. BOOSTRIX also is linked to the protein Mucin-1 (human), which contributes to cellular processes and dysregulation, and can facilitate in distinct human diseases. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
The role of exotoxin A in pseudomonas disease and immunity https://pubmed.ncbi.nlm.nih.gov/6419320/
Mucin-1 (human)
Mucin 1 - Protein-Disease Associations - https://pubchem.ncbi.nlm.nih.gov/protein/P15941 - section=Diseases-and- Phenotypes
Diphtheria toxoids
https://www.cdc.gov/vaccines/pubs/pinkbook/dip.html
4. Hib* Haemophilus influenzae type b
PedvaxHIB (PRP-OMP, Merck) -
Synonym: Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol Modified For Conjugation
This vaccine is contraindicated for name. because it contains the chemical Atropine, which is registered as a hazardous substances, and an environmental contaminant. Atropine in toxic amounts leads to drowsiness, stupor, convulsions, & coma, and death. Symptoms of atropine toxicity include: dryness of the mouth; flushed, hot, & dry skin; dilated & nonreactive pupils; tachycardia; hallucinations; & restlessness. Seizures without prior evidence of hallucinations or delirium have followed the use of atropine in children. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
haemophilus b conjugate vaccine (meningococcal protein conjugate) https://www.drugs.com/pro/pedvaxhib.html
Atropine -
Atropine has been used as a premedication in obstetric anesthesia, as a test of fetoplacental insufficiency, & in the diagnosis of fetal asphyxia (atropine given to the mother produces changes in the fetal heart rate: first bradycardia, then tachycardia). There is evidence of rapid placental transfer of atropine. https://pubchem.ncbi.nlm.nih.gov/source/hsdb/2199
Atropine Data sheet –
https://pubchem.ncbi.nlm.nih.gov/compound/Atropine - section=GHS-Classification
Neisseria Meningitidis Serogroup B (B-11 Strain) Outer Membrane Protein Complex Thiol Modified For Conjugation
https://gsrs.ncats.nih.gov/ginas/app/beta/substances/MC95ZF3C5A https://gsrs.ncats.nih.gov/ginas/app/beta/substances/46KSF1PRP7
5. PCV13, PCV15 (Pneumococcal disease)
Name: Vaxneuvance (Merck) Pneumococcal 15-valent - suspension for injection in pre-filled syringe
This vaccine is contraindicated for name because it contains Amlodipine (Norvasc). Amlodipine is an antihypertensive agent, and a vasodilator agent; which can cause a decrease in blood pressure. *GHS Hazard Statements - Toxic if swallowed. Danger Acute toxicity, oral corrosive, and an environmental contaminant. Causes serious eye damage. Causes damage to organs through prolonged or repeated exposure. *Warning: Specific target organ toxicity, repeated exposure. Very toxic to aquatic life with long lasting effects. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence
Amlodipine https://pubchem.ncbi.nlm.nih.gov/compound/amlodipine
Norvasc
https://www.mayoclinic.org/drugs-supplements/amlodipine-oral-route/description/drg-20061784
Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient] (Code N0000179488)
https://nciterms.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NDFRT&version=February2018&code=N0 000179488&ns=NDFRT&type=all&key=null&b=1&n=0&vse=null
6. IPV - Poliovirus Vaccine, inactivated
This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can produce neurotoxicity, ototoxicity and/or nephrotoxicity. Neomycin is associated with delayed-onset irreversible deafness, renal failure and death due to neuromuscular blockade (regardless of the status of renal function). GHS Hazard Statements: Harmful if swallowed: Acute toxicity, oral. May cause a serious allergic skin reaction May cause allergy or asthma symptoms or breathing difficulties if inhaled. Inactivated poliovirus vaccine administration has been associated with Guillain-Barre Syndrome. *Neomycin is used in veterinary medicine as a bactericidal drug. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Neomycin https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
7. COVID-19** Coronavirus disease 2019
This recombinant nanoparticle vaccine is contraindicated for name because it contains the full-length spike glycoprotein of the prototype strain plus *Matrix-M adjuvant. Matrix-M adjuvant induces early activation of innate immune cells at the injection site and in the draining lymph nodes. It is unsafe when used in larger amounts as medicine. The Matrix-M adjuvant consists of two distinct fractions of saponins purified from the Quillaja saponaria Molina tree, combined with cholesterol and phospholipids to form 40-nm open cage-like nanoparticles. Quillaia contains high amounts of tannins which can cause stomach problems, as well as kidney and liver damage. Quillaia also contains chemicals called oxalates, which can cause kidney stones. Additional serious adverse events with this vaccine: cases of myocarditis, cases of pericarditis, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in hospitalization or death following administration of the Novavax COVID-19 Vaccine, Adjuvanted. *NVX-CoV2373 in the United States has received Emergency Use Authorization, it is not FDA approved
This presents a clear medical danger to name because this toxins, and the additional adverse health concerns would be exacerbated by introduction of this substance to his/her body.
FDA Briefing Document Novavax COVID-19 Vaccine
https://www.fda.gov/media/158912/download
Supporting studies/evidence
Matrix-MTM Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041451
Additional information on Novavax
*The Novavax COVID-19 Vaccine, Adjuvanted is a suspension for intramuscular injection.
Product label Generic name: nvx-cov2373 Dosage form: injection, suspension Drug class: Viral vaccines Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report all vaccine administration errors, all serious adverse events, cases of myocarditis, cases of pericarditis, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in hospitalization or death following administration of the Novavax COVID-19 Vaccine, Adjuvanted.
See “MANDATORY REQUIREMENTS FOR THE NOVAVAX COVID-19 VACCINE, ADJUVANTED ADMINISTRATION UNDER EMERGENCY USE AUTHORIZATION” for reporting requirements. https://www.drugs.com/pro/covid-19-vaccine-novavax.html
8. Flu† Influenza
This vaccine is contraindicated for name because it can trigger severe allergic reactions such as asthma and precaution is advised with use of quadrivalent live attenuated influenza vaccine (LAIV4) in persons aged ≥5 years because of concerns for wheezing events. Reactions include, in addition to asthma (e.g., anaphylaxis) egg, (egg protein) neuralgia, paresthesia, convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse myelitis, Guillain-Barre Syndrome, dizziness, hypoesthesia, tremor, facial or cranial nerve paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell's Palsy), exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis, eosinophilic meningitis, vaccine associated encephalitis. This presents a clear medical danger to name because these potentially dangerous medical concern would be exacerbated by introduction of this vaccine to his/her body.
Supporting studies/evidence:
FLUMIST
QUADRIVALENT safely and effectively. See full prescribing information for FLUMIST https://www.fda.gov/vaccines-blood-biologics/lot-release/influenza-vaccine-2022-2023-seasonAfluria Quadrivalent 2022-2023 (injection)
https://www.drugs.com/mtm/afluria-quadrivalent-2022-2023-injection.html https://www.drugs.com/sfx/afluria-quadrivalent-side-effects.html
9. MMR Measles, Mumps, & Rubella
This vaccine is contraindicated for name, and certain individuals including those with: a history of hypersensitivity to any component of the vaccine, including gelatin; a history of anaphylactic reaction to *Neomycin; individuals who are immunodeficient or immunosuppressed due to disease or medical therapy; an active febrile illness. Adverse concerns/ reactions are seizure or family history of febrile seizures; immediate-type hypersensitivity reactions to eggs; and thrombocytopenia. These medical concerns and reactions presents a clear medical danger to name due to ingredients that would be exacerbated by introduction of these substance to his/her body.
Supporting studies/evidence:
MMR Vaccine - Priorix https://www.chop.edu/news/news-views-what-should-i-know-about-new-mmr-vaccine-priorix
Priorix
https://ca.gsk.com/media/6254/priorix.pdf
*Neomycin
https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
10. Varicella (Chickenpox)
This vaccine is contraindicated for name because it contains the chemical compound, ALB - albumin (human). Implicated in several diseases, including blood protein disease; hepatobiliary system cancer (multiple); hyperthyroxinemia; middle cerebral artery infarction; and psoriasis. Biomarker of several diseases, including carcinoma (multiple); heart disease (multiple); hematologic cancer (multiple); liver disease (multiple); and lung disease (multiple). This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body. *Note: This gene has been reviewed for its involvement in coronavirus biology, and is relevant for COVID- 19 prognosis.
Supporting Studies/evidence:
ALB - albumin (human). https://pubchem.ncbi.nlm.nih.gov/gene/213
Albumin (human)
https://www.drugs.com/mtm/albumin-human.html
11. HepA‡ Hepatitis A
This vaccine is contraindicated for name because it contains Aluminum. Aluminum negatively effects the central nervous system and bones. Aluminum binds to dietary phosphorus and impairs gastrointestinal absorption of aluminum. The decreased phosphate body burden results in osteomalacia and rickets. Aluminum neurotoxicity is believed to involve different mechanisms. Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier, cholinergic activity, signal transduction pathways. It has been suggested that aluminum’s interaction with estrogen receptors increases the expression of estrogen-related genes and thereby contributes to the progression of breast cancer. This presents a clear medical danger to name because this chemical compound is toxic, and would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Havrix
(Hepatitis A Vaccine) injectable suspension, for intramuscular use https://ca.gsk.com/media/6243/havrix.pdfAl2O3 nanoparticles induce mitochondria-mediated cell death and upregulate the expression of signaling genes in human mesenchymal stem cells
https://pubmed.ncbi.nlm.nih.gov/23132795/
12. Tdap: ≥7 yrs.
This vaccine is contraindicated for name because it contains Neomycin, a chemical compound that can produce neurotoxicity, ototoxicity and/or nephrotoxicity. Severe allergic reaction (e.g., anaphylaxis) and progressive neurologic disorders, include - hypersensitivity and encephalopathy. Neomycin is associated with delayed-onset irreversible deafness, renal failure and death due to neuromuscular blockade (regardless of the status of renal function). Neomycin is used in veterinary medicine as a bactericidal drug. GHS Hazard Statements: Harmful if swallowed - Warning Acute toxicity, oral. May cause an allergic skin reaction May cause allergy or asthma symptoms or breathing difficulties if inhaled. This presents a clear medical danger to name because this toxin would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Neomycin https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
Neomycin
https://pubchem.ncbi.nlm.nih.gov/compound/neomycin
*Neomycin - Necrosis - The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. Associated Disorders and Diseases. DNA Degradation, Necrotic - The random catabolism of DNA accompanying the irreversible damage to tissue which leads to the pathological death of one or more cells. https://pubchem.ncbi.nlm.nih.gov/compound/neomycin - section=Associated-Disorders-and-Diseases
13 (HPV) Human Papillomavirus
This vaccine is contraindicated for name because it contains serious health concerns for anyone with allergic food (yeast), Adverse side effects associated HPV vaccine are: difficulty breathing, wheezing (bronchospasm), hives, rash, vomiting, swollen glands (neck, armpit, or groin) joint pain unusual tiredness, weakness, or confusion, chills, generally feeling unwell, leg pain, shortness of breath, chest pain, aching muscles, muscle weakness, seizure, bleeding or bruising more easily than normal, skin infection. *There are 85 Papillomavirus type strains (including non -human strains) linked to this CDC Recommended Vaccine. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
Patient Information about GARDASIL
9 (Human Papillomavirus 9-valent Vaccine, Recombinant) https://www.fda.gov/media/90070/download?attachment*Patent Summary: Vaccine against HPV – 85 linked Papillomavirus strains
https://pubchem.ncbi.nlm.nih.gov/patent/EP-2318042-B1 - section=Linked-Proteins
14. Meningococcal (MenACWY-D: ≥9 mos, MenACWY-CRM: ≥2 mos, MenACWY-TT: ≥2years)
This vaccine is contraindicated for name because it contains the chemical compound, Diphtheria Toxoid. As an ingredient, it is a carrier protein for polysaccharides and haptens to make them immunogenic. The toxicity of Diphtheria Toxoid (CRM197) can cause damage to yeast cells and some mammalian cell lines. Haptens are small molecules that elicit an immune response when attached to a large carrier such as a protein; and they activate responses involving inflammatory cytokines. *Examples of post market side adverse effects, associated with this vaccine include (not limited too) - Blood and Lymphatic System Disorders, Lymphadenopathy, Immune System Disorders, Hypersensitivity reactions such as anaphylaxis/anaphylactic reaction, wheezing, difficulty breathing, upper airway swelling, urticaria, erythema, pruritus, and hypotension. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Supporting studies/evidence:
LABEL: MENACTRA-
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen injection, solution https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d8781ff-9366-462c-8161- 6e958f44fcb4&audience=consumer - S11
Menactra
, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccinehttps://www.vaccineshoppe.com/assets/pdf/vsh/pi/menactrapi.pdf
15. Meningococcal serogroup B vaccination
This vaccine is contraindicated for name because it contains an ingredient, Fc gamma receptor and transporter (FCGRT). This gene encodes a receptor that binds immunoglobulin G; and also binds immunoglobulin G to protect the antibody from degradation. Due to alternative splicing caused by interaction with various ingredients in the vaccine, multiple transcript variant can occur, and trigger autoimmune reactions. Disease associated with FCGRT is Myasthenia gravis. Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies destroy the communication between nerves and muscle, resulting in weakness of the skeletal muscles. Myasthenia gravis affects the voluntary muscles of the body, especially those that control the eyes, mouth, throat and limbs. The disease can strike anyone at any age. A myasthenia gravis crisis can involve difficulty in swallowing or breathing. The cause of myasthenia gravis is unknown and there is no cure. *The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This presents a clear medical danger to name because these toxins would be exacerbated by introduction of this substance to his/her body.
Meningococcal group B vaccine Side Effects
https://www.drugs.com/sfx/meningococcal-group-b-vaccine-side-effects.html
Myasthenia Gravis
https://www.hopkinsmedicine.org/health/conditions-and-diseases/myasthenia-gravis
16. (PPSV23) pneumococcal polysaccharides vaccine (PPSV), 23-valent
This vaccine is contraindicated for name because it contains such harsh ingredients, and known toxins that trigger life threatening allergic reactions, and onset infections. A few examples of these life-threatening reactions are: Febrile convulsion, which are seizures or convulsions that occur in young children. Symptoms may include: loss of consciousness or passing out; uncontrollable shaking; eye rolling; rigid (stiff) limbs. Myocardial infarction (commonly called a heart attack) is an extremely dangerous condition that happens because of a lack of blood flow to your heart muscle; often resulting in death. Injection Cellulitis; Cellulitis is a potentially serious bacterial skin infection. The affected skin is swollen and inflamed and is typically painful and warm to the touch. Cellulitis is usually a superficial infection of the skin; if severe or if left untreated, it can spread into the lymph nodes and bloodstream and rapidly become life-threatening. These potential reactions presents a clear medical danger to name because these reactions would be exacerbated by introduction of this substance to his/her body.
PNEUMOVAX 23 is indicated to help prevent pneumococcal disease caused by 23 serotypes
https://www.merckvaccines.com/pneumovax23/
Pneumovax 23 Side Effects
Generic name: pneumococcal 23-polyvalent vaccine
https://www.drugs.com/sfx/pneumovax-23-side-effects.html
Febrile Seizures
https://www.ninds.nih.gov/health-information/disorders/febrile-seizures
Heart Attack (Myocardial Infarction)
https://my.clevelandclinic.org/health/diseases/16818-heart-attack-myocardial-infarction
Cellulitis
https://www.mayoclinic.org/diseases-conditions/cellulitis/symptoms-causes/syc-20370762
17. (DEN4CYD: 9-16 yrs.)
1. This vaccine is contraindicated for name because it has extreme adverse side effects, causing damaging health concerns. Some of them were: bleeding (tourniquet, petechiae or any bleeding) plus plasma leakage; Shock and hypotension with tachycardia, weak pulse and poor perfusion; Bleeding requiring blood transfusion; Encephalopathy i.e., unconsciousness or poor conscious state; poor conscious state or unconsciousness; Myocarditis, and pericarditis.
2. Sanofi Pasteur licensed the first dengue vaccine (Dengvaxia
) in Mexico in 2015, and more than 20 countries, thereafter, based on the safety and efficacy demonstrated in two phase III trials and a single season of disease surveillance. Unfortunately, the optimism that a dengue vaccine was finally available quickly became disappointment when a safety signal was observed in vaccine recipients who were dengue non-immune at the time of vaccine administration44,45. In the third year of the phase III clinical trial, the youngest, non-immune vaccine recipients experienced increased rates of hospitalized and severe dengue compared to their unvaccinated peers46. These potential reactions presents a clear medical danger to name because these toxins and/or reactions would be exacerbated by introduction of this substance to his/her body.
1. Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
https://classic.clinicaltrials.gov/ct2/show/NCT01374516
2. Is new dengue vaccine efficacy data a relief or cause for concern?
https://www.nature.com/articles/s41541-023-00658-2
*Additional Information:
HepA Hepatitis A Vaccines - Associated Disorders and Diseases
Autism Spectrum Disorder
Multiple Sclerosis, Chronic Progressive Bone Diseases, Metabolic Cardiovascular Diseases
Brain Diseases
Anemia
Eye Diseases
Memory Disorders
Cognition Disorders
Granuloma
Heart Defects, Congenital
Epilepsy, Tonic-Clonic
Fragile X Syndrome
Inflammation
Lung Diseases
Osteomalacia
Lymphadenitis
Nerve Degeneration
Parkinson Disease
Neoplasms
Osteoporosis
Bronchial Hyperreactivity
Multiple Sclerosis, Relapsing-Remitting Neurodegenerative Diseases
Chronic Kidney Disease-Mineral and Bone Disorder Chemical and Drug Induced Liver Injury
Poisoning
Diabetes Complications
Dyslipidemias
Respiratory Tract Diseases
Neurotoxicity Syndromes
Weight Loss
Heavy Metal Poisoning
Patent - Vaccine against HPV - GLAXOSMITHKLINE BIOLOG SA (BE)
(HPV) Human Papillomavirus Stains - Presented as linked
Proteins in Vaccine
P50805 P08341 P50807 P03104 P11326 P22163 Q02273 Q02274 P06456 P06417 P04012 P03099 P25486 P17388 P06416 P27232 P24838 P27557 P27233 P50815 P50816 P36741 P22424 P26536 P36743 P26535 P26537 P69899 P27964 P36733 P36734 Q05137 Q02514 Q02050 Q02051 Q02515 P36731 P36740 P36742
Major capsid protein L1 (Xipapillomavirus 1)
Major capsid protein L1 (Bos taurus papillomavirus 4)
Major capsid protein L1 (Bos taurus papillomavirus 6)
Major capsid protein L1 (Deltapapillomavirus 2)
Major capsid protein L1 (Deltapapillomavirus 1)
Major capsid protein L1 (Alpha papillomavirus 12)
Major capsid protein L1 (human papillomavirus 13)
Major capsid protein L1 (Pygmy chimpanzee papillomavirus type 1) Major capsid protein L1 (Chaffinch papillomavirus)
Major capsid protein L1 (Human papillomavirus type
Major capsid protein L1 (human papillomavirus 11)
Major capsid protein L1 (Human papillomavirus type 1a)
Major capsid protein L1 (Human papillomavirus type 2a)
Major capsid protein L1 (human papillomavirus 31)
Major capsid protein L1 (human papillomavirus 33)
Major capsid protein L1 (human papillomavirus 35)
Major capsid protein L1 (human papillomavirus 39)
Major capsid protein L1 (Human papillomavirus type 41)
Major capsid protein L1 (human papillomavirus 42)
Major capsid protein L1 (human papillomavirus 43)
Major capsid protein L1 (human papillomavirus 44)
Major capsid protein L1 (human papillomavirus 45)
Major capsid protein L1 (human papillomavirus 47)
Major capsid protein L1 (human papillomavirus 51)
Major capsid protein L1 (human papillomavirus 56)
Major capsid protein L1 (human papillomavirus 58)
Major capsid protein L1 (Human papillomavirus type 5b)
Major capsid protein L1 (Human papillomavirus type 6b)
Major capsid protein L1 (Human papillomavirus type me180) Major capsid protein L1 (human papillomavirus 12)
Major capsid protein L1 (human papillomavirus 14)
Major capsid protein L1 (Human papillomavirus 15)
Major capsid protein L1 (Human papillomavirus 17) Major capsid protein L1 (Human papillomavirus 19) Major capsid protein L1 (human papillomavirus 25) Major capsid protein L1 (human papillomavirus 30)
Major capsid protein L1 (Human papillomavirus 3) Major capsid protein L1 (human papillomavirus 40) Major capsid protein L1 (Human papillomavirus type 49)
Q07860 Major capsid protein L1 (Human papillomavirus 4) Q05138 Major capsid protein L1 (human papillomavirus 52) Q05136 Major capsid protein L1 (Human papillomavirus type 7) Q02480 Major capsid protein L1 (Human papillomavirus 9) Q07861 Major capsid protein L1 (Human papillomavirus type 63) Q07874 Major capsid protein L1 (Human papillomavirus 65)
P50786 Major capsid protein L1 (human papillomavirus 20)
P50787 Major capsid protein L1 (human papillomavirus 21)
P03102 Major capsid protein L1 (Papillomavirus sylvilagi
(STRAIN KANSAS))
P50791 Major capsid protein L1 (Human papillomavirus 28)
P50792 Major capsid protein L1 (Human papillomavirus 29)
P50820 Major capsid protein L1 (Human papillomavirus type 55) P50822 Major capsid protein L1 (Human papillomavirus type 61) P50824 Major capsid protein L1 (Human papillomavirus type 64) Q80961 Major capsid protein L1 (human papillomavirus 66)
P50825 Major capsid protein L1 (human papillomavirus 67)
P50826 Major capsid protein L1 (human papillomavirus 69)
P69898 Major capsid protein L1 (Human papillomavirus type 6a)
P50788 Major capsid protein L1 (Human papillomavirus 22)
P50789 Major capsid protein L1 (Human papillomavirus 23)
P50790 Major capsid protein L1 (human papillomavirus 24)
P50812 Major capsid protein L1 (human papillomavirus 36)
P50813 Major capsid protein L1 (Human papillomavirus 37)
P50814 Major capsid protein L1 (Human papillomavirus 38)
P50793 Major capsid protein L1 (Human papillomavirus type 70) P50806 Major capsid protein L1 (Epsilon papillomavirus 1)
P50817 Major capsid protein L1 (Human papillomavirus type 48)
P50818 Major capsid protein L1 (Human papillomavirus type 50)
P50821 Major capsid protein L1 (Human papillomavirus type 60) P54669 Major capsid protein L1 (human papillomavirus 68) Q9IR52 Major capsid protein L1 (human papillomavirus 82) P36736 Major capsid protein L1 (human papillomavirus 27) P22162 Major capsid protein L1 (human papillomavirus 57) P36732 Major capsid protein L1 (Human papillomavirus type 10) P03101 Major capsid protein L1 (Human papillomavirus type 16) P06794 Major capsid protein L1 (Human papillomavirus type 18) P36735 Major capsid protein L1 (Human papillomavirus type 26)
P36737 Major capsid protein L1 (Human papillomavirus type 32)
P36738 Major capsid protein L1 (Human papillomavirus type 34)
Q05113 Major capsid protein L1 (Human papillomavirus type 53)
P06917 Major capsid protein L1 (Human papillomavirus 5)
P50823 Major capsid protein L1 (human papillomavirus 62)
P03103 Major capsid protein L1 (Deltapapillomavirus 4)
Q89828 Major capsid protein L1 (Canine oral papillomavirus (strain Y62)) P50819 Major capsid protein L1 (Human papillomavirus type 54)
P06458 Major capsid protein L1 (Bos taurus papillomavirus 2)
